Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/4/26 21:35 | 11/2/26 | NTRA | Health | Health | Medical Laboratories | Sheena Jonathan | TX | DH | CO-FOUND | 7 | S.m | -14,317 | 372.31 | 0 | -38 | 267 | D | |||||||||||||||
11/4/26 21:35 | 11/2/26 | NTRA | Health | Health | Medical Laboratories | Rabinowitz Matthew | TX | DO | Exec CB | 6 | S.dm | -72,845 | 286.27 | 0 | -254 | 4,282 | D | |||||||||||||||
11/4/26 21:35 | 11/2/26 | NTRA | Health | Health | Medical Laboratories | Rabinowitz Daniel | TX | O | SEC.,GC | 2 | S.m | -908 | 414.05 | 0 | -2 | 168 | D | |||||||||||||||
11/4/26 21:35 | 11/2/26 | NTRA | Health | Health | Medical Laboratories | Moshkevich Solomon | TX | O | P,CLINIC | 4 | S.m | -9,467 | 353.89 | 0 | -27 | 111 | D | |||||||||||||||
11/4/26 21:35 | 11/2/26 | NTRA | Health | Health | Medical Laboratories | Fesko John | TX | O | P,CHIEF | 3 | S.m | -2,916 | 343.16 | 0 | -8 | 197 | D | |||||||||||||||
11/4/26 21:35 | 11/2/26 | NTRA | Health | Health | Medical Laboratories | Chapman Steven Leonard | TX | DO | CEO,P | 4 | S.m | -5,018 | 402.53 | 0 | -12 | 98 | D | |||||||||||||||
11/4/26 21:35 | 11/2/26 | NTRA | Health | Health | Medical Laboratories | Brophy Michael Burkes | TX | O | CFO | 3 | S.m | -2,455 | 419.14 | 0 | -6 | 50 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |